Europe — EMA
Nebivolol Macleods
GNH USA supplies Nebivolol Macleods (Nebivolol), a beta blocker indicated for hypertension and heart failure management.
Request sourcing
What is Nebivolol?
Nebivolol, the active ingredient in Nebivolol Macleods, is a beta blocker presented as a tablet for oral use. It treats hypertension and heart failure in adult patients.
GNH USA supplies Nebivolol Macleods as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Nebivolol used for?
Nebivolol is a beta‑blocker used in the management of cardiovascular conditions.
Hypertension: lowers elevated blood pressure in adult patients. Heart failure: improves symptoms and functional capacity in chronic heart failure. Cardiovascular risk reduction: enhances endothelial function, contributing to overall cardiovascular health.
What are the side effects of Nebivolol?
Nebivolol may cause a range of adverse reactions.
Common Side Effects: - Headache - Dizziness - Fatigue - Nausea - Bradycardia - Peripheral edema
Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm in patients with asthma - Allergic reactions such as rash or angioedema - Hepatic enzyme elevation - Acute heart failure decompensation
What precautions apply to Nebivolol?
Nebivolol requires careful clinical monitoring.
Monitor blood pressure: ensure adequate control without excessive drop. Assess heart rate: watch for bradycardia, especially in patients with conduction disorders. Use caution in asthma or chronic obstructive pulmonary disease: β‑blockade may precipitate bronchospasm. Adjust dose in renal impairment: reduced clearance may increase exposure. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.
What does Nebivolol interact with?
Nebivolol can interact with several medicines.
Major Interactions (Avoid): - Other β‑blockers: additive negative chronotropic effects. - Calcium‑channel blockers (verapamil, diltiazem): increased risk of AV block. - Strong CYP2D6 inhibitors (paroxetine, fluoxetine): may raise nebivolol plasma levels.
Moderate Interactions (Monitor Closely): - NSAIDs: may attenuate antihypertensive efficacy. - Diuretics: combined use can enhance hypotensive response. - Antidiabetic agents: nebivolol may mask hypoglycemia symptoms.



